<DOC>
	<DOC>NCT01743404</DOC>
	<brief_summary>The purpose of this study is to investigate the anti-atherosclerotic effect of long-term anti-inflammatory therapy (Inflaminat) in asymptomatic participants with subclinical atherosclerosis of carotid arteries.</brief_summary>
	<brief_title>Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>Men aged 40 to 70 years Subclinical carotid atherosclerosis detected by Bmode ultrasound (increased intimamedia thickness 10002000 mcm) Arterial normotension or mild arterial hypertension (systolic blood pressure &lt;160 mm Hg, diastolic blood pressure &lt;90 mm Hg) Absence of chronic diseases demanding permanent drug administration (more than 2 month per year) Personal history of stroke or transient ischemic attacks Chronic diseases demanding drug administration more than during 2 month per year Individual intolerance of Inflaminat or appearance of side effects</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>atherosclerosis</keyword>
	<keyword>inflammation</keyword>
	<keyword>intima-media thickness</keyword>
</DOC>